| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cassava Sciences Inc (SAVA) has 9 insiders with recent SEC Form 4 filings, including 10 buys and 12 sells. SAVA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 938.1K | $2.59M | - | |
| Dir | 53.0K | - | - | |
| Dir | 26.5K | - | - | |
| Dir | 26.5K | - | - | |
| Dir | 26.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2019 | Barbier Remi | President And CEO | Buy | 10,000 | $4.15 | $41,500.00 | +1.0% | |
| Dec 20, 2019 | Robertson Sanford | Director | Buy | 423,788 | $2.20 | $932,333.60 | +177.4% | |
| Dec 19, 2019 | Schoen Eric | Chief Financial Officer | Buy | 5,300 | $1.88 | $9,964.00 | +53.0% | |
| Dec 19, 2019 | Robertson Sanford | Director | Buy | 76,212 | $1.86 | $141,754.32 | +46.9% | |
| Dec 18, 2019 | Barbier Remi | President And CEO | Buy | 2,599 | $1.65 | $4,288.35 | New | |
| May 14, 2019 | Schoen Eric | Chief Financial Officer | Buy | 10,000 | $1.06 | $10,600.00 | New | |
| Oct 3, 2018 | Armistice Capital, LLC56 | 10% Owner | Sell | 512,660 | $1.31 | $671,738.40 | -23.7% | |
| Sep 27, 2018 | Robertson Sanford | Director | Buy | 37,817 | $1.05 | $39,707.85 | +30.3% | |
| Sep 26, 2018 | Robertson Sanford | Director | Buy | 62,183 | $1.02 | $63,341.76 | +27.2% | |
| Aug 20, 2018 | Armistice Capital, LLC56 | 10% Owner | Sell | 1,256,000 | $1.02 | $1,275,136.00 | -6.0% |